P
Prashant N. Mohite
Researcher at Harefield Hospital
Publications - 132
Citations - 1770
Prashant N. Mohite is an academic researcher from Harefield Hospital. The author has contributed to research in topics: Ventricular assist device & Lung transplantation. The author has an hindex of 22, co-authored 132 publications receiving 1495 citations. Previous affiliations of Prashant N. Mohite include Government Medical College, Thiruvananthapuram & PGi.
Papers
More filters
Journal ArticleDOI
Evaluation of the Organ Care System in Heart Transplantation With an Adverse Donor/Recipient Profile
Diana García Sáez,Bartlomiej Zych,Anton Sabashnikov,Christopher T. Bowles,Fabio De Robertis,Prashant N. Mohite,Aron-Frederik Popov,Olaf Maunz,Nikhil P. Patil,Alexander Weymann,T. Pitt,Louise McBrearty,Bradley Pates,R. Hards,Mohamed Amrani,Toufan Bahrami,Nicholas R. Banner,Andre R. Simon +17 more
TL;DR: Use of the TransMedics Organ Care System is associated with markedly improved short-term outcomes and transplant activity by allowing use of organs previously not considered suitable for transplantation or selection of higher risk recipients, or both.
Journal ArticleDOI
Clinical Experience With HeartWare Left Ventricular Assist Device in Patients With End-Stage Heart Failure
Aron Frederik Popov,Morteza Tavakkoli Hosseini,Bartlomiej Zych,Prashant N. Mohite,R. Hards,Heike Krueger,Toufan Bahrami,Mohamed Amrani,Andre R. Simon +8 more
TL;DR: Although cardiac transplantation remains the gold standard for treatment of end-stage heart failure patients, the HeartWare VAD can be used as a safe alternative with a satisfactory clinical outcome.
Journal ArticleDOI
CentriMag® short-term ventricular assist as a bridge to solution in patients with advanced heart failure: use beyond 30 days
Prashant N. Mohite,Bartlomiej Zych,Aron Frederik Popov,Anton Sabashnikov,Diana García Sáez,Nikhil P. Patil,Mohamed Amrani,Toufan Bahrami,Fabio DeRobertis,Olaf Maunz,Nandor Marczin,Nicholas R. Banner,Andre R. Simon +12 more
TL;DR: CentriMag proved to be a versatile, safe and effective short-term circulatory support for patients with advanced heart failure as a bridge to solution and its use over 30 days is associated with acceptable survival and does not increase device-related complications.
Journal ArticleDOI
Lung transplantation from donors outside standard acceptability criteria--are they really marginal?
Bartlomiej Zych,Diana García Sáez,Anton Sabashnikov,Fabio De Robertis,Mohamed Amrani,Toufan Bahrami,Prashant N. Mohite,Nikhil P. Patil,Alexander Weymann,Aron Frederik Popov,Anna Reed,Martin Carby,Andre R. Simon +12 more
TL;DR: Carefully selected donor lungs from outside the standard acceptability criteria may expand existing donor pool with no detrimental effect on LTx outcome.
Journal ArticleDOI
Long-term results after lung transplantation using organs from circulatory death donors: a propensity score-matched analysis †
Anton Sabashnikov,Nikhil P. Patil,Aron-Frederik Popov,Simona Soresi,Bartlomiej Zych,Alexander Weymann,Prashant N. Mohite,Diana García Sáez,Mohamed Zeriouh,Thorsten Wahlers,Yeong-Hoon Choi,Jens Wippermann,Thorsten Wittwer,Fabio De Robertis,Toufan Bahrami,Mohamed Amrani,Andre R. Simon +16 more
TL;DR: Long-term results after LTx with organs procured following DCD are in general comparable with those obtained after DBD LTx, however, patients transplanted using organs from DCD donors have a predisposition for development of BOS in the longer follow-up.